Copyright
©The Author(s) 2022.
World J Psychiatry. Jul 19, 2022; 12(7): 944-957
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944
Table 5 Number of comorbid diagnoses
| MA group, n = 54 | OS group, n = 55 | P | |
| Depression | 11 | 15 | 0.40 |
| Anxiety disorder | 5 | 0 | 0.03 |
| Eating disorder | 0 | 2 | 0.49 |
| Obsessive-compulsive disorder | 0 | 0 | - |
| Posttraumatic stress disorder | 15 | 12 | 0.47 |
| Personality disorder | 11 | 11 | 0.96 |
| ADHD | 6 | 7 | 0.80 |
| Psychotic disorder | 3 | 10 | 0.042 |
| Somatoform disorder | 18 | 0 | < 0.001 |
- Citation: Behle N, Kamp F, Proebstl L, Hager L, Riebschläger M, Schacht-Jablonowsky M, Hamdorf W, Neumann S, Krause D, Manz K, Franke AG, Koller G, Soyka M. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users. World J Psychiatry 2022; 12(7): 944-957
- URL: https://www.wjgnet.com/2220-3206/full/v12/i7/944.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i7.944